PerspectiveCancer Biomarkers

Going with the Flow: From Circulating Tumor Cells to DNA

Science Translational Medicine  16 Oct 2013:
Vol. 5, Issue 207, pp. 207ps14
DOI: 10.1126/scitranslmed.3006305

You are currently viewing the abstract.

View Full Text

Log in


Abstract

Molecular analyses of circulating tumor DNA (ctDNA) in plasma from cancer patients have the potential to deliver minimally invasive diagnostic and disease-monitoring biomarkers. Drawing from experience gained through the translation of circulating tumor cell detection to clinical tests, we discuss ctDNA as a source of tumor material for biomarker development.

View Full Text